TL-Pharmacy: Your Trusted Source of Quality Pharmaceuticals

What are the symptoms of in-situ breast cancer?

Mar, 3 2023| 0 Comments

In situ breast cancer is a very early form of the disease, in which cancerous cells remain in the place of origin, in the lining of the ducts or lobules. Symptoms of in situ breast cancer include a lump, an area of thickening, an area of firmness, or a change in the size, shape or texture of the breast. In some cases, there may be no obvious signs or symptoms. A diagnostic mammogram or other imaging test is required for diagnosis. Treatment of in situ breast cancer usually involves surgery to remove the cancerous tissue and may be followed by radiation or hormone therapy.

Latest Post

Why are flat cells more likely to become metastatic?

0 Comments Mar, 9 2023

Flat cells, or squamous cells, are more likely to become metastatic than cuboidal cells. This is due to the fact that flat cells have a greater surface area to volume ratio. This means that they have a greater ability to absorb nutrients, which allows them to proliferate and spread more quickly than cuboidal cells. Additionally, flat cells are more likely to attach to surfaces, which helps them to spread more easily. Finally, flat cells are more likely to form protrusions, which helps them to penetrate barriers and migrate more easily.

Chlorthalidone and Diabetes: Managing Blood Sugar Levels

0 Comments Apr, 27 2023

As a blogger, I recently came across the topic of Chlorthalidone and its role in managing blood sugar levels for diabetics. Chlorthalidone is a diuretic medication primarily used to treat high blood pressure, but it has also been found to aid in blood sugar control. While it's not a primary treatment for diabetes, incorporating this medication can be beneficial for those struggling with both hypertension and diabetes. It is essential to consult with a healthcare professional before starting any new medication, including Chlorthalidone. I will continue to explore this topic and share my findings with my readers, as managing blood sugar levels is crucial for diabetics.

What is the difference between lesion and tumor?

0 Comments Apr, 20 2023

Lesions and tumors are both growths that can appear on or in the body, but there are important differences between the two. Lesions are typically benign, non-cancerous growths that can be caused by a variety of factors, such as infection, inflammation, trauma, or abnormal cell growth. Tumors, on the other hand, are abnormal growths that can be either benign or cancerous. They are caused by abnormal cell growth, and they can spread to other areas of the body if left untreated. Lesions are typically treated with antibiotics or other medications, while tumors require more aggressive treatments, such as surgery, radiation therapy, or chemotherapy. Lesions and tumors can both cause pain, but tumors tend to cause more severe symptoms. Ultimately, it is important to seek medical attention if you experience any abnormal growths on or in your body.

When and how does uterine cancer spread?

0 Comments Mar, 6 2023

Uterine cancer, also known as endometrial cancer, is a type of cancer that originates in the lining of the uterus. It is the most common type of cancer affecting the uterus. Uterine cancer can spread to other parts of the body, such as the lymph nodes and lungs, through a process known as metastasis. The cancer cells can spread through the bloodstream and lymphatic system. Risk factors for uterine cancer include age, obesity, endometrial hyperplasia, diabetes, and taking estrogen without progesterone. Treatment options for uterine cancer include surgery, radiation therapy, and chemotherapy.

How rare is cancer?

0 Comments Mar, 2 2023

Cancer is a serious and potentially life-threatening disease, but it is not as rare as many people think. According to the World Health Organization, cancer is the second leading cause of death worldwide. In 2018, there were an estimated 18.1 million new cases of cancer and 9.6 million cancer-related deaths. While cancer is not as rare as many people believe, early detection and improved treatments have led to increasing survival rates. In the United States, five-year survival rates for all cancers combined increased from 49.3% in 1975-1977 to 69.5% in 2006-2012.